Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Feb 25, 2011

Sage-N to Co-Market Its Proteomics Platform with Nonlinear Dynamics' LC/MS Software

  • Sage-N Research signed an agreement to co-market Nonlinear Dynamics’ Progenesis LC/MS label-free quantification software alongside its Sorcerer proteomics platform. Sage-N‘s Sorcerer uses the Sequest 3G algorithm to enable identification and characterization of low-abundance phospho-proteins and post-translational modifications (PTMs).

    Sorcerer also features high-level server-based solutions for storage and back-up of the complex data-sets generated by third-party applications such as the Progenesis LC/MS software as well as  rapid processing of those data-sets, according to Sage-N.

    The Progenesis LC/MS software quantifies peptides and proteins independently of identification. It can be used for both differential protein-expression and protein-characterisation applications. The software is designed to integrate with a wide range of instrumentation, Nonlinear Dynamics reports.

    Users of Sorcerer include The Sanford-Burnham Medical Research Institute. In November Sage-N said the institute had implemented the Sorcerer Enterprise platform, which has integrated back-up and storage as well as real-time data replication, for its large-scale data analyses.

     



Related content

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »